TIAA Trust National Association Sells 1,874 Shares of Elevance Health, Inc. $ELV

TIAA Trust National Association trimmed its position in Elevance Health, Inc. (NYSE:ELV) by 27.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,922 shares of the company’s stock after selling 1,874 shares during the period. TIAA Trust National Association’s holdings in Elevance Health were worth $1,590,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vermillion & White Wealth Management Group LLC grew its position in Elevance Health by 94.9% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock valued at $30,000 after buying an additional 37 shares during the period. BOK Financial Private Wealth Inc. purchased a new position in shares of Elevance Health during the 2nd quarter worth $32,000. Physician Wealth Advisors Inc. boosted its stake in shares of Elevance Health by 331.6% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock worth $26,000 after acquiring an additional 63 shares during the last quarter. Rossby Financial LCC grew its position in shares of Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after acquiring an additional 44 shares during the period. Finally, Activest Wealth Management increased its stake in shares of Elevance Health by 66.7% in the 3rd quarter. Activest Wealth Management now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on ELV. Wall Street Zen lowered Elevance Health from a “buy” rating to a “hold” rating in a report on Sunday, February 8th. Wolfe Research set a $425.00 price objective on Elevance Health and gave the company an “outperform” rating in a research report on Thursday, January 8th. Weiss Ratings lowered shares of Elevance Health from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 2nd. Sanford C. Bernstein lowered their price target on shares of Elevance Health from $431.00 to $409.00 and set an “outperform” rating on the stock in a report on Friday, January 30th. Finally, TD Cowen reiterated a “buy” rating on shares of Elevance Health in a research report on Wednesday, November 26th. Twelve analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $390.55.

Elevance Health Trading Down 0.7%

Elevance Health stock opened at $320.65 on Friday. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $458.75. The firm’s 50 day moving average price is $350.23 and its 200-day moving average price is $335.70. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.54 and a quick ratio of 1.54. The stock has a market cap of $70.77 billion, a P/E ratio of 12.76, a PEG ratio of 1.77 and a beta of 0.50.

Elevance Health (NYSE:ELV) last posted its earnings results on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, beating the consensus estimate of $3.10 by $0.23. The company had revenue of $49.31 billion during the quarter, compared to analysts’ expectations of $49.52 billion. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. Elevance Health’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the company posted $3.84 earnings per share. Elevance Health has set its FY 2026 guidance at 25.500- EPS. On average, equities analysts predict that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 25th. Shareholders of record on Tuesday, March 10th will be paid a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from Elevance Health’s previous quarterly dividend of $1.71. Elevance Health’s dividend payout ratio is presently 27.23%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.